Home » Topics » Regulatory

Regulatory
RSS

Approvable letter received for Metadate sprinkle administration

April 2, 2002

Dynepo receives E.U. approval for anemia of renal failure

March 28, 2002

Zindaclin launched in the U.K. as once-daily acne treatment

March 27, 2002

Roche's MabThera and Xeloda cleared for new indications in Europe

March 26, 2002

Remicade granted priority review as Crohn's disease monotherapy

March 25, 2002

Label change for Xenical cleared by CPMP

March 25, 2002

FDA approval for Avinza for once-daily treatment of chronic pain

March 22, 2002

Health Canada approves expanded label for ProstaScint

March 20, 2002

FDA approval for new formulation of Visicol

March 18, 2002

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.